0007-0920
Semimonthly
No
BRIT J CANCER
1947
413
ENGLAND
http://www.nature.com/bjc/index.html
平均6月審稿時(shí)間
約95%平均錄用比例
5.416影響因子
腫瘤學(xué)小學(xué)科
月期刊平臺(tái)服務(wù)過的文章錄用時(shí)間為1-3個(gè)月,依據(jù)20年經(jīng)驗(yàn),經(jīng)月期刊專家預(yù)審?fù)ㄟ^后的文章,投稿通過率100%以上!
英國(guó)癌癥雜志是癌癥研究運(yùn)動(dòng)的官方雜志,由該運(yùn)動(dòng)資助的年度研究報(bào)告發(fā)展而成。該雜志反映了這一運(yùn)動(dòng)的使命,包括對(duì)整個(gè)癌癥領(lǐng)域的研究,從分子和機(jī)械研究,到細(xì)胞生物學(xué)、病理學(xué)、實(shí)驗(yàn)治療學(xué)、流行病學(xué)和臨床研究報(bào)告。在科學(xué)亞專業(yè)化程度不斷提高的時(shí)代,對(duì)一本覆蓋范圍廣泛的一流期刊的需求至關(guān)重要;更重要的是,最佳臨床實(shí)踐意味著對(duì)單個(gè)癌癥患者進(jìn)行多學(xué)科護(hù)理。北京辛普勞吸引了廣大觀眾,這反映在其一貫令人印象深刻的影響因素。它的受歡迎程度使其規(guī)模翻了一番,并向每?jī)芍艹霭嬉淮蔚姆较虬l(fā)展。除了完整的研究論文外,該雜志還出版高質(zhì)量的評(píng)論、信件、書評(píng)、未來(lái)會(huì)議和會(huì)議的日程表,偶爾還出版會(huì)議補(bǔ)充資料?!度A爾街日?qǐng)?bào)》已經(jīng)為“快速通道”的文章做了規(guī)定,這大大減少了編輯和審稿人認(rèn)為適當(dāng)?shù)臏贤ǖ恼3霭鏁r(shí)間?!度A爾街日?qǐng)?bào)》擁有一個(gè)非常龐大的專家評(píng)審員國(guó)際數(shù)據(jù)庫(kù),這保證了所有提交文章的同行評(píng)審的高標(biāo)準(zhǔn)。通常情況下,提交給期刊的每一份研究稿至少要有三名審稿人。
http://www.nature.com/bjc/authors/submit.html
British Journal of Cancer is the official journal of the Cancer Research Campaign and developed from the annual reports of research funded by the Campaign. The journal reflects the mission of the Campaign by including research on the entire field of cancer, ranging from molecular and mechanistic studies, through cell biology, pathology, experimental therapeutics, epidemiology and accounts of clinical studies. In a time of increased subspecialization in science, the need for a top-rate journal with broad coverage is paramount; all the more so as best clinical practice means multidisciplinary care for individual cancer patients. BJC appeals to a broad audience, which is reflected in its consistently impressive impact factors. Its popularity has led to a doubling in size and a move to biweekly publication. In addition to full research papers, the journal publishes high quality reviews, correspondence, book reviews, a calendar of future meetings and conferences and, occasionally, conference supplements. The journal has made provision for 'fast track' articles, which reduces considerably the normal publication time for communications deemed by the Editors and reviewers to be appropriate. The journal has a very large international database of expert reviewers and this guarantees high standards of peer review for all submitted articles. Normally a minimum of three reviewers are employed for each research manuscript submitted to the journal.
快速預(yù)審、投刊前指導(dǎo)、專業(yè)學(xué)術(shù)評(píng)審,對(duì)文章進(jìn)行評(píng)價(jià);
立即咨詢校對(duì)編輯、深度潤(rùn)色,讓稿件符合學(xué)術(shù)規(guī)范,格式體例等標(biāo)準(zhǔn);
立即咨詢適用于語(yǔ)句和結(jié)構(gòu)尚需完善和調(diào)整的中文文章,確保稿件達(dá)到要求;
立即咨詢數(shù)據(jù)庫(kù)包括:期刊、文章、書籍、會(huì)議、預(yù)印書、百科全書和摘要等;
立即咨詢讓作者在期刊選擇時(shí)避免走彎路,縮短稿件被接收的周期;
立即咨詢根據(jù)目標(biāo)期刊格式要求對(duì)作者文章進(jìn)行全面的格式修改和調(diào)整;
立即咨詢幫助作者將稿件提交至目標(biāo)期刊投稿系統(tǒng),降低退稿或拒稿率;
立即咨詢按照您提供的稿件內(nèi)容,指導(dǎo)完成投稿附信(cover letter);
立即咨詢大類學(xué)科同領(lǐng)域優(yōu)質(zhì)期刊 | 大類學(xué)科 | 小類學(xué)科 | 影響因子 | 分區(qū) | ISSN |
---|---|---|---|---|---|
ACTA ONCOLOGICA | 醫(yī)學(xué) | 腫瘤學(xué) | 3.298 | 3區(qū) | 0284-186X |
Advances in Cancer Research | 醫(yī)學(xué) | 腫瘤學(xué) | 4.667 | N/A | 0065-230X |
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 醫(yī)學(xué) | 腫瘤學(xué) | 3.015 | N/A | 0277-3732 |
ANNALS OF ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 14.196 | N/A | 0923-7534 |
ANNALS OF SURGICAL ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 3.681 | N/A | 1068-9265 |
ANTI-CANCER DRUGS | 醫(yī)學(xué) | 腫瘤學(xué) | 1.801 | N/A | 0959-4973 |
ANTICANCER RESEARCH | 醫(yī)學(xué) | 腫瘤學(xué) | 1.935 | N/A | 0250-7005 |
Asia-Pacific Journal of Clinical Oncology | 醫(yī)學(xué) | 腫瘤學(xué) | 1.539 | N/A | 1743-7555 |
BMC CANCER | 醫(yī)學(xué) | 腫瘤學(xué) | 2.933 | N/A | 1471-2407 |
Brachytherapy | 醫(yī)學(xué) | 腫瘤學(xué) | 2.03 | 4區(qū) | 1538-4721 |
發(fā)現(xiàn)心儀選題請(qǐng)?zhí)顔?/b>
獲取發(fā)表周期短、審稿速度快容易錄用的期刊